4436-74-2 Purity
98%
If you have any other questions or need other size, please get a quote.
Specification
The molecular formula of Pazopanib is C21H23N7O2S.
Pazopanib was first created on October 25, 2006.
The molecular weight of Pazopanib is 437.5 g/mol.
The mechanism of action of Pazopanib is as a Protein Kinase Inhibitor, Cytochrome P450 3A4 Inhibitor, Cytochrome P450 2D6 Inhibitor, and Cytochrome P450 2C8 Inhibitor.
Pazopanib was FDA approved on October 19, 2009.
Some synonyms for Pazopanib are Pazopanibum, GW786034, and 444731-52-6.
Pazopanib is described as an antineoplastic agent, a tyrosine kinase inhibitor, a vascular endothelial growth factor receptor antagonist, and an angiogenesis modulating agent.
The IUPAC Name of Pazopanib is 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide.
The InChIKey of Pazopanib is CUIHSIWYWATEQL-UHFFFAOYSA-N.
Some other identifiers for Pazopanib include CAS number 444731-52-6, UNII 7RN5DR86CK, and DSSTox Substance ID DTXSID8048733.